Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dexbrompheniramine
2. Disophrol
1. 2391-03-9
2. Disomer
3. (+)-brompheniramine Maleate
4. (s)-brompheniramine Maleate
5. Brompheniramine D-form Maleate
6. Chebi:59273
7. Dexbrompheniramine Fumarate
8. Bpa9ut29bs
9. 2391-03-9 (maleate)
10. Dsstox_cid_27795
11. Dsstox_rid_82567
12. Dsstox_gsid_47818
13. Dexbrompheniramine Maleate (usp)
14. Dexbrompheniramine Maleate [usp]
15. Disomer Maleate
16. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine Maleate
17. 2-pyridinepropanamine, G-(4-bromophenyl)-n,n-dimethyl-, (gs)-,(2z)-2-butenedioate (1:1)
18. Cas-2391-03-9
19. Ncgc00162100-02
20. Alahist Ir
21. Alahist Pe
22. Disomer (tn)
23. D-brompheniramine Maleate
24. Unii-bpa9ut29bs
25. Mls001401374
26. Schembl217770
27. 3-(2-hydroxyphenyl)benzoicacid
28. Chembl1200638
29. Dtxsid6047818
30. (+)-brompheniramine Maleate Salt
31. Hms2051f10
32. Hms2235o07
33. Hms3260p05
34. Einecs 219-236-2
35. Tox21_112000
36. Tox21_500232
37. Bdbm50247924
38. Akos015962824
39. Tox21_112000_1
40. Ac-1161
41. Ccg-101017
42. Lp00232
43. Nc00267
44. Ncgc00015146-11
45. Ncgc00093697-01
46. Ncgc00260917-01
47. Dexbrompheniramine Maleate [mart.]
48. Dexbrompheniramine Maleate [vandf]
49. Smr000471616
50. Dexbrompheniramine Maleate [usp-rs]
51. Dexbrompheniramine Maleate [who-dd]
52. Brompheniramine D-form Maleate [mi]
53. Eu-0100232
54. B 5275
55. D03704
56. Dexbrompheniramine Maleate [orange Book]
57. Dexbrompheniramine Maleate [usp Monograph]
58. Sr-01000075719
59. Disobrom Component Dexbrompheniramine Maleate
60. Disophrol Component Dexbrompheniramine Maleate
61. Drixoral Component Dexbrompheniramine Maleate
62. Resporal Component Dexbrompheniramine Maleate
63. Sr-01000075719-1
64. Brompheril Component Dexbrompheniramine Maleate
65. Dexbrompheniramine Maleate Component Of Disobrom
66. Dexbrompheniramine Maleate Component Of Drixoral
67. Dexbrompheniramine Maleate Component Of Resporal
68. Q27126583
69. Dexbrompheniramine Maleate Component Of Brompheril
70. Dexbrompheniramine Maleate Component Of Disophrol
71. Drixoral Plus Component Dexbrompheniramine Maleate
72. Dexbrompheniramine Maleate Component Of Drixoral Plus
73. (+)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine Maleate
74. (s)-1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane Maleate
75. (s)-2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine Maleate
76. (+)-2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate
77. (+)-3-(4-bromophenyl)-n,n-dimethyl-3-(2-pyridinyl)-1-propanamine Maleate
78. (+)-3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine Maleate
79. (s)-3-(4-bromophenyl)-n,n-dimethyl-3-(2-pyridinyl)-1-propanamine Maleate
80. (s)-3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine Maleate
81. (+)-2-(p-bromo-.alpha.-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)
82. (+)-2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate (1:1)
83. (+)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
84. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine (2z)-but-2-enedioate
85. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
86. (3s)-3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine;(z)-but-2-enedioic Acid
87. (s)-2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridinium (z)-maleate (1:1)
88. (s)-3-(4-bromophenyl)-n,n-dimethyl-3-(pyridin-2-yl)propan-1-amine Maleate
89. Dexbrompheniramine Maleate, United States Pharmacopeia (usp) Reference Standard
90. Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, Maleate (1:1), (s)-
91. 2-pyridinepropanamine, G-(4-bromophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1)
92. 2-pyridinepropanamine, Gamma-(4-bromophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1)
Molecular Weight | 435.3 g/mol |
---|---|
Molecular Formula | C20H23BrN2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 434.08412 g/mol |
Monoisotopic Mass | 434.08412 g/mol |
Topological Polar Surface Area | 90.7 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Dexbrompheniramine Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexbrompheniramine Maleate, including repackagers and relabelers. The FDA regulates Dexbrompheniramine Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexbrompheniramine Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexbrompheniramine Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dexbrompheniramine Maleate supplier is an individual or a company that provides Dexbrompheniramine Maleate active pharmaceutical ingredient (API) or Dexbrompheniramine Maleate finished formulations upon request. The Dexbrompheniramine Maleate suppliers may include Dexbrompheniramine Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Dexbrompheniramine Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dexbrompheniramine Maleate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dexbrompheniramine Maleate active pharmaceutical ingredient (API) in detail. Different forms of Dexbrompheniramine Maleate DMFs exist exist since differing nations have different regulations, such as Dexbrompheniramine Maleate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dexbrompheniramine Maleate DMF submitted to regulatory agencies in the US is known as a USDMF. Dexbrompheniramine Maleate USDMF includes data on Dexbrompheniramine Maleate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dexbrompheniramine Maleate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dexbrompheniramine Maleate suppliers with USDMF on PharmaCompass.
A Dexbrompheniramine Maleate written confirmation (Dexbrompheniramine Maleate WC) is an official document issued by a regulatory agency to a Dexbrompheniramine Maleate manufacturer, verifying that the manufacturing facility of a Dexbrompheniramine Maleate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dexbrompheniramine Maleate APIs or Dexbrompheniramine Maleate finished pharmaceutical products to another nation, regulatory agencies frequently require a Dexbrompheniramine Maleate WC (written confirmation) as part of the regulatory process.
click here to find a list of Dexbrompheniramine Maleate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexbrompheniramine Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexbrompheniramine Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexbrompheniramine Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexbrompheniramine Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexbrompheniramine Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexbrompheniramine Maleate suppliers with NDC on PharmaCompass.
Dexbrompheniramine Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexbrompheniramine Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexbrompheniramine Maleate GMP manufacturer or Dexbrompheniramine Maleate GMP API supplier for your needs.
A Dexbrompheniramine Maleate CoA (Certificate of Analysis) is a formal document that attests to Dexbrompheniramine Maleate's compliance with Dexbrompheniramine Maleate specifications and serves as a tool for batch-level quality control.
Dexbrompheniramine Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Dexbrompheniramine Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexbrompheniramine Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexbrompheniramine Maleate EP), Dexbrompheniramine Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexbrompheniramine Maleate USP).
LOOKING FOR A SUPPLIER?